Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NanoPharmaSolutions, Inc. logo — Phase-transition technology platform for enhancing solubilit...

NanoPharmaSolutions, Inc.

Phase-transition technology platform for enhancing solubility of BCS 2 & 4 APIs without the use of exogenous chemicals

Founded 2019 United States San Diego, United States 4 employees Seed Biotechnology, Pharmaceutical

General Information

Company Name NanoPharmaSolutions, Inc.
Founded Year 2019
Location United States San Diego, United States +1
Employees 4
Industries Biotechnology, Pharmaceutical
Funding Stage Seed
Social

Get notified when NanoPharmaSolutions, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NanoPharmaSolutions, Inc.

Nano PharmaSolutions (NPS) has developed the platform nanodrug delivery technology, NanoTransformer® that generates nanoparticles of small molecule drugs without using lipids or polymers. NanoTransformer is the only drug nanoparticle generation process that uses phase-transition technology to enhance the solubility of BCS 2 and BCS 4 APIs without the use of excipients. The cGMP manufacturing facility opens in 2024. Nano PharmaSolutions delivers CNS therapeutics through nose to bring delivery using NanoTransformer process. This clean nanotechnology can safely and effectively deliver drugs to brain through the nose because it doesn't contain other chemicals for nanoengineering.

Taxonomy: nanodrug delivery technology, biopharmaceuticals, drug nanoparticle generation, phase-transition technology, solubility enhancement, cGMP manufacturing, CNS therapeutics, innovative nanoformulation, excipient-free drug delivery, vaporized API deposition, drug bioavailability enhancement, nose-to-brain drug delivery, nanotechnology, patented technology platform, API solubility enhancement

No funding data available for NanoPharmaSolutions, Inc. yet.

Get notified when NanoPharmaSolutions, Inc. raises funding

NanoPharmaSolutions, Inc. Alternatives & Competitors

NanoPharmaSolutions, Inc. vs
Rexis Biotech
Rexis Biotech United States

Groundbreaking Nanotechnology

11 employees
Biotechnology, Pharmaceutical
NanoPharmaSolutions, Inc. vs
Lyra Therapeutics
Lyra Therapeutics

Innovative solutions for precise, localized treatments in ear, nose, and throat care.

Post Ipo Equity
51-200 employees
Biotechnology, Health Care
NanoPharmaSolutions, Inc. vs
Synartro
Synartro Sweden

Developing injection treatments that provide local slow release with minimal systemic burden

Series A
6 employees
Biotechnology, Health and Wellness

FAQ About NanoPharmaSolutions, Inc.

Phase-transition technology platform for enhancing solubility of BCS 2 & 4 APIs without the use of exogenous chemicals
NanoPharmaSolutions, Inc. was founded in 2019.
NanoPharmaSolutions, Inc. is headquartered in San Diego, United States.
NanoPharmaSolutions, Inc. operates in the following industries: Biotechnology, Pharmaceutical.
NanoPharmaSolutions, Inc. has approximately 4 employees.
Top alternatives and competitors to NanoPharmaSolutions, Inc. include Rexis Biotech, Lyra Therapeutics, Synartro, Disruptive Pharma AB, Zosano Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NanoPharmaSolutions, Inc. and Rexis Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NanoPharmaSolutions, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes